ProCE Banner Activity

New Treatments for RRMM: A Focus on Immunotherapy and Novel Approaches


Download these slides from a live symposium for an overview of novel treatment options and considerations with the newest immunotherapy approaches for relapsed/refractory multiple myeloma.

Released: December 18, 2023



Thomas G. Martin

Thomas G. Martin, MD

Clinical Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Co-Lead, Cancer Immunology and Immunotherapy Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC in partnership with the International Myeloma Foundation

ProCE Banner


Supported by educational grants from Karyopharm Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc

Sanofi Genzyme


International Myeloma Foundation

ProCE Banner